Evidence map›Paper›PMID 37259395›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

In Vitro Hemocompatibility and Genotoxicity Evaluation of Dual-Labeled [

María Alejandra Asensio Ruiz, Ángela Alonso García, María de la Luz Bravo-Ferrer Moreno, Iria Cebreiros-López, José Antonio Noguera-Velasco, Antonio Abel Lozano-Pérez, Teresa Martínez Martínez

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

María Alejandra Asensio RuizServicio de Radiofarmacia, Hospital Clínico Universitario Virgen de la Arrixaca, 30120 Murcia, Spain.
Ángela Alonso GarcíaServicio de Radiofarmacia, Hospital Clínico Universitario Virgen de la Arrixaca, 30120 Murcia, Spain.
María de la Luz Bravo-Ferrer MorenoServicio de Radiofarmacia, Hospital Clínico Universitario Virgen de la Arrixaca, 30120 Murcia, Spain.
Iria Cebreiros-LópezInstituto Murciano de Investigación Biosanitaria (IMIB)-Arrixaca, 30120 Murcia, Spain.ORCID 0000-0002-8588-7880
José Antonio Noguera-VelascoInstituto Murciano de Investigación Biosanitaria (IMIB)-Arrixaca, 30120 Murcia, Spain.ORCID 0000-0001-6786-4864
Antonio Abel Lozano-PérezInstituto Murciano de Investigación Biosanitaria (IMIB)-Arrixaca, 30120 Murcia, Spain.ORCID 0000-0002-5749-3737
Teresa Martínez MartínezServicio de Radiofarmacia, Hospital Clínico Universitario Virgen de la Arrixaca, 30120 Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria · ESHospital Universitario Virgen de la Arrixaca · ES

Funding

European Commission ERDF/FEDER Operational Program 'Murcia' CCI No. 2007ES161PO001 (Project No. 14-20/20)MCIN/AEI/10.13039/501100011033 PID2020-113081RB-I00
6 · The paper itself

Abstract

Nuclear imaging is a highly sensitive and noninvasive imaging technique that has become essential for medical diagnosis. The use of radiolabeled nanomaterials capable of acting as imaging probes has shown rapid development in recent years as a powerful, highly sensitive, and noninvasive tool. In addition, quantitative single-photon emission computed tomography (SPECT) images performed by incorporating radioisotopes into nanoparticles (NPs) might improve the evaluation and the validation of potential clinical treatments. In this work, we present a direct method for [

Indexed as

99mTcCBMN assayFITCgenotoxicityhemocompatibilitymultimodal imagingnuclear imagingradiolabelingsilk fibroin NPsSPECT

Identifiers

PMID37259395
PMCPMC9959965
OpenAlexW4319599395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.